drugset / Trial / NCT01260376

Effect of Pharmacological Anti-lipolysis on FFA and VLDL-TG Metabolism Before and During Exercise

NCT01260376

Completed 9 enrolled University of Aarhus
RandomizedCrossoverDouble-blindBasic science

Summary

This study will investigate free fatty acid and VLDL-TG metabolism before and during exercise with and without pharmacological antilipolysis by the niacin antagonist Acipimox. Main focuses will be VLDL-TG and free fatty acid metabolism as well as expression of membrane proteins in fat- and muscle biopsies.

Timeline

Start
2011-04
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Acipimox Small molecule 250 mg